Cerity Partners LLC Boosts Holdings in Semler Scientific, Inc. (NASDAQ:SMLR)

Cerity Partners LLC raised its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 91.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,345,586 shares of the company’s stock after buying an additional 642,982 shares during the period. Cerity Partners LLC owned about 0.19% of Semler Scientific worth $31,689,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. CWM LLC raised its holdings in Semler Scientific by 486.3% in the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares during the period. Newbridge Financial Services Group Inc. bought a new stake in Semler Scientific during the second quarter valued at about $34,000. Quest Partners LLC purchased a new stake in Semler Scientific in the second quarter worth about $59,000. Meeder Asset Management Inc. bought a new position in shares of Semler Scientific in the second quarter worth about $67,000. Finally, US Bancorp DE raised its stake in shares of Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after buying an additional 1,158 shares during the period. 49.37% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Semler Scientific

In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total transaction of $283,500.00. Following the completion of the sale, the chief executive officer now directly owns 60,220 shares of the company’s stock, valued at $1,707,237. This trade represents a 14.24 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 30.20% of the company’s stock.

Semler Scientific Trading Down 4.2 %

Shares of NASDAQ:SMLR opened at $63.65 on Monday. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $76.98. The company has a market cap of $462.74 million, a PE ratio of 31.05 and a beta of 0.92. The stock has a 50 day moving average of $32.45 and a 200 day moving average of $30.85.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The firm had revenue of $13.51 million during the quarter.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.